A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 4,404 shares of TMDX stock, worth $354,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,404
Previous 4,726 6.81%
Holding current value
$354,433
Previous $711,000 2.81%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$135.68 - $176.11 $43,688 - $56,707
-322 Reduced 6.81%
4,404 $691,000
Q2 2024

Jul 16, 2024

SELL
$72.62 - $150.62 $100,869 - $209,211
-1,389 Reduced 22.71%
4,726 $711,000
Q1 2024

May 06, 2024

SELL
$70.86 - $89.93 $10,345 - $13,129
-146 Reduced 2.33%
6,115 $452,000
Q4 2023

Feb 07, 2024

BUY
$36.74 - $81.08 $93,723 - $206,835
2,551 Added 68.76%
6,261 $494,000
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $198,373 - $356,419
3,710 New
3,710 $203,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.56B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.